These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32102637)

  • 41. H2 blockers in the intensive care unit: ignoring the evidence? Telephone survey.
    Wyncoll DL; Roberts PC; Beale RJ; McLuckie A
    BMJ; 1997 Apr; 314(7086):1013. PubMed ID: 9112846
    [No Abstract]   [Full Text] [Related]  

  • 42. Gastric acid suppressants--too much of a good thing?
    Logan IC; Sumukadas D; Witham MD
    Age Ageing; 2010 Jul; 39(4):410-1. PubMed ID: 20507846
    [No Abstract]   [Full Text] [Related]  

  • 43. Prevention of stress ulceration: current trends in critical care.
    Daley RJ; Rebuck JA; Welage LS; Rogers FB
    Crit Care Med; 2004 Oct; 32(10):2008-13. PubMed ID: 15483408
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The end of the era of maintenance therapy for peptic ulcer disease?
    Chiba T
    J Gastroenterol; 2000; 35(11):873. PubMed ID: 11085499
    [No Abstract]   [Full Text] [Related]  

  • 45. Intravenous proton pump inhibitors for stress ulcer prophylaxis in critically ill patients: determining statistical equivalence according to evidence-based methods.
    Messori A; Fadda V; Maratea D; Gatto R; Trippoli S; De Rosa M; Marinai C
    Int J Clin Pharmacol Ther; 2014 Oct; 52(10):825-9. PubMed ID: 25074869
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of a clinical pharmacist stress ulcer prophylaxis management program on inappropriate use in hospitalized patients.
    Buckley MS; Park AS; Anderson CS; Barletta JF; Bikin DS; Gerkin RD; O'Malley CW; Wicks LM; Garcia-Orr R; Kane-Gill SL
    Am J Med; 2015 Aug; 128(8):905-13. PubMed ID: 25820164
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Proton Pump Inhibitors Versus Histamine-2 Receptor Antagonists Likely Increase Mortality in Critical Care: An Updated Meta-Analysis.
    Lee TC; Goodwin Wilson M; Lawandi A; McDonald EG
    Am J Med; 2021 Mar; 134(3):e184-e188. PubMed ID: 32931766
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Question: Should gastric protection with a histamine2-receptor blocker or a proton pump inhibitor be ordered for stress ulcer prophylaxis on virtually every adult patient admitted to the hospital for something other than elective surgery?
    Hopkins L; Stockert K; Coyner C; Palmer P
    J Okla State Med Assoc; 2011 Mar; 104(3):85-6. PubMed ID: 21608449
    [No Abstract]   [Full Text] [Related]  

  • 49. Efficacy and safety of proton pump inhibitors versus histamine-2 receptor blockers in the cardiac surgical population: insights from the PEPTIC trial.
    van Diepen S; Coulson T; Wang X; Opgenorth D; Zuege DJ; Harris J; Agyemang M; Niven DJ; Bellomo R; Wright SE; Young PJ; Bagshaw SM;
    Eur J Cardiothorac Surg; 2022 Jul; 62(2):. PubMed ID: 35213716
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stress-related mucosal bleeding in critically ill oncology patients.
    Bruno JJ; Canada TW; Wakefield CD; Nates JL
    J Oncol Pharm Pract; 2009 Mar; 15(1):9-16. PubMed ID: 18753185
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antisecretory therapy for bleeding peptic ulcer.
    Peterson WL; Cook DJ
    JAMA; 1998 Sep; 280(10):877-8. PubMed ID: 9739959
    [No Abstract]   [Full Text] [Related]  

  • 52. Stress ulcer prophylaxis versus placebo or no prophylaxis in adult hospitalised acutely ill patients-protocol for a systematic review with meta-analysis and trial sequential analysis.
    Marker S; Perner A; Wetterslev J; Barbateskovic M; Jakobsen JC; Krag M; Granholm A; Anthon CT; Møller MH
    Syst Rev; 2017 Jun; 6(1):118. PubMed ID: 28646925
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Famotidine versus pantoprazole.
    Lwin AA
    Am J Crit Care; 2008 Jul; 17(4):311-2; author reply 312. PubMed ID: 18593828
    [No Abstract]   [Full Text] [Related]  

  • 54. Stress Ulcer Prophylaxis in Critically Ill Children: A Multicenter Observational Study.
    Duffett M; Chan A; Closs J; McGloin R; McKelvie G; Pong S; Seto W; Slaney H; Vaninetti G; Vanniyasingam T
    Pediatr Crit Care Med; 2020 Feb; 21(2):e107-e113. PubMed ID: 31821206
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Incidence of gastro-duodenal stress lesions in trauma patients requiring intensive care, treated with secretory inhibitors. A double blind study].
    Barandun J; Leutenegger A; Frutiger A; Rüedi T; Kobler E
    Schweiz Rundsch Med Prax; 1984 Sep; 73(38):1145-6. PubMed ID: 6149610
    [No Abstract]   [Full Text] [Related]  

  • 56. Cost-effectiveness of histamine receptor-2 antagonist versus proton pump inhibitor for stress ulcer prophylaxis in critically ill patients*.
    MacLaren R; Campbell J
    Crit Care Med; 2014 Apr; 42(4):809-15. PubMed ID: 24365863
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Off-label use of gastrointestinal medications in the intensive care unit.
    Barletta JF; Lat I; Micek ST; Cohen H; Olsen KM; Haas CE;
    J Intensive Care Med; 2015 May; 30(4):217-25. PubMed ID: 24362446
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The authors reply.
    MacLaren R; Campbell J
    Crit Care Med; 2014 Sep; 42(9):e637-8. PubMed ID: 25126823
    [No Abstract]   [Full Text] [Related]  

  • 59. Opinions and practice of stress ulcer prophylaxis in Australian and New Zealand intensive care units.
    Eastwood GM; Litton E; Bellomo R; Bailey MJ; Festa M; Beasley RW; Young PJ
    Crit Care Resusc; 2014 Sep; 16(3):170-4. PubMed ID: 25161018
    [TBL] [Abstract][Full Text] [Related]  

  • 60. On the need for observational studies to design and interpret randomized trials in ICU patients: a case study in stress ulcer prophylaxis.
    Cook D; Heyland D; Marshall J;
    Intensive Care Med; 2001 Feb; 27(2):347-54. PubMed ID: 11396278
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.